Epilepsy
📧 Sign up to get email alerts when something new happens for Epilepsy.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2017-03-14Clinical Trial Update: Ketogenic Diet for Refractory Status Epilepticus [NA]
This clinical trial evaluated the ketogenic diet as a treatment for refractory status epilepticus and related seizures; the study led by Joh…
-
CLINICAL_TRIALS research · 2017-03-14Clinical Trial Update: A Study to Look at Antiepileptic Drug Levels While on Lamictal or Depakote With or Without an Oral Contraceptive
This completed clinical trial investigated antiepileptic drug levels in participants taking lamotrigine (Lamictal) or valproic acid (Depakot…
-
CLINICAL_TRIALS trial_result · 2017-03-13Clinical Trial Update: Effect of Antiseizure Medication on Hormone Levels and Sexual Function in Men With Epilepsy
A completed clinical trial evaluated the effect of an antiseizure medication on hormone levels and sexual function in men with epilepsy.
-
CLINICAL_TRIALS research · 2017-03-13Clinical Trial Update: Yoga for Patients With Epilepsy [NA]
A completed clinical trial evaluating yoga as a potential intervention for epilepsy. The update notes the study status but does not present …
-
CLINICAL_TRIALS withdrawal · 2017-03-13Clinical Trial Update: Pre-oxygenation and Measures of Gas Exchanges During Seizures in the Epilepsy Monitoring Unit [NA]
A clinical trial investigating pre-oxygenation and gas-exchange measurements during seizures in the Epilepsy Monitoring Unit has been termin…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2017-03-10FDA Approved: CEREBYX — Supplemental Application (Pfizer Laboratories Div Pfizer Inc)
The FDA approved a supplemental application for Cerebyx (fosphenytoin sodium) from Pfizer Laboratories Div Pfizer Inc. The approval updates …
-
CLINICAL_TRIALS trial_result · 2017-03-09Clinical Trial Update: An Open Label Study of L059 (Levetiracetam) in Japanese Epilepsy Subjects With Generalized Tonic-clonic Seizures [Phase 3]
This is a completed Phase 3 open-label study of levetiracetam (L059) in Japanese epilepsy patients with generalized tonic-clonic seizures. R…
-
CLINICAL_TRIALS trial_result · 2017-03-09Clinical Trial Update: Study to Investigate Dosage, Efficacy, and Safety of Perampanel Given as Monotherapy in Patients With Epilepsy
This entry notes a completed clinical trial evaluating the dosage, efficacy, and safety of perampanel as monotherapy in patients with epilep…
-
CLINICAL_TRIALS research · 2017-03-08Clinical Trial Update: Risk Factors of SUDEP
This clinical trial update examines risk factors for SUDEP in people with epilepsy; the current study status is unknown.
-
FDA approval · 2017-03-07FDA Approved: APTIOM — Supplemental Application (Sumitomo Pharma America, Inc.)
The FDA approved a supplemental application for APTIOM (eslicarbazepine acetate) submitted by Sumitomo Pharma America, Inc.
-
FDA approval · 2017-03-06FDA Approved: DEPAKOTE SPRINKLES — Supplemental Application (AbbVie Inc.)
FDA approves a supplemental application for Depakote Sprinkles (divalproex sodium) from AbbVie, authorizing changes to the product labeling …
-
CLINICAL_TRIALS research · 2017-03-03Clinical Trial Update: Evaluation of Onfi Conversion Therapy Replacing Clonazepam in Patients With Medically Refractory Epilepsy [Phase 4]
This Phase 4 clinical trial evaluates converting patients from clonazepam to Onfi (clobazam) in medically refractory epilepsy.
-
FDA approval · 2017-03-01FDA Approved: CEREBYX — Supplemental Application (Pfizer Laboratories Div Pfizer Inc)
The FDA approved a supplemental application for Cerebyx (fosphenytoin sodium) submitted by Pfizer Laboratories Div Pfizer Inc.
-
CLINICAL_TRIALS trial_result · 2017-02-23Clinical Trial Update: Efficacy, Safety, and Tolerability of Oxcarbazepine Monotherapy in Children With Partial Seizures [Phase 4]
Phase 4 trial in children with partial seizures assessed the efficacy, safety, and tolerability of oxcarbazepine monotherapy.
-
CLINICAL_TRIALS trial_result · 2017-02-23Clinical Trial Update: Doxycycline for the Treatment of Nodding Syndrome [Phase 2]
Phase 2 clinical trial evaluating doxycycline for nodding syndrome; the current status is not disclosed.
-
FDA approval · 2017-02-01FDA Approved: DILANTIN — Supplemental Application (Viatris Specialty LLC)
FDA approved a supplemental application for DILANTIN (Extended Phenytoin Sodium) by Viatris Specialty LLC.
-
CLINICAL_TRIALS research · 2017-01-30Clinical Trial Update: Diffusion Tensor Imaging in Epilepsy With Continuous Spikes and Waves During Sleep
This clinical trial update covers diffusion tensor imaging in epilepsy with continuous spikes and waves during sleep in cryptogenic epilepsy…
-
FDA approval · 2017-01-25FDA Approved: FOSPHENYTOIN SODIUM — Supplemental Application (Hikma Pharmaceuticals USA Inc.)
FDA approved a supplemental application for fosphenytoin sodium from Hikma Pharmaceuticals USA Inc., confirming continued marketing of the g…
-
CLINICAL_TRIALS research · 2017-01-25Clinical Trial Update: Effect of Outpatient Classic Ketogenic Diet in Epileptic Children and Adolescent. [Phase 2]
This document reports a Phase 2 clinical trial assessing the effect of an outpatient classic ketogenic diet in children and adolescents with…
-
CLINICAL_TRIALS trial_result · 2017-01-18Clinical Trial Update: Pediatric Epilepsy Study in Subjects 1-24 Months [Phase 2]
Phase 2 pediatric epilepsy trial in children aged 1-24 months has completed.
-
CLINICAL_TRIALS trial_result · 2017-01-18Clinical Trial Update: A Double-blind, Randomized Conversion to Monotherapy Study to Evaluate the Efficacy and Safety of Brivaracetam in Subjects (≥ 16 to 75 Years Old) With Partial Onset Seizures [Phase 3]
A Phase 3 double-blind trial evaluating brivaracetam as monotherapy in adults with partial-onset seizures was terminated, with results poste…
-
CLINICAL_TRIALS trial_result · 2017-01-18Clinical Trial Update: LevetIracetam in Patients Being Treated for Epilepsy
A completed clinical trial evaluating levetiracetam in patients with epilepsy; the update does not include published efficacy or safety resu…
-
CLINICAL_TRIALS trial_result · 2017-01-13Clinical Trial Update: Effect of Auditory Stimulation on Spike Waves in Sleep [NA]
A completed clinical trial studied whether auditory stimulation affects spike-wave activity during sleep in individuals with epilepsy.
-
FDA approval · 2017-01-09FDA Approved: PHENYTOIN — Supplemental Application (Sun Pharmaceutical Industries, Inc.)
The FDA approved a supplemental application for phenytoin submitted by Sun Pharmaceutical Industries, Inc.
-
CLINICAL_TRIALS trial_result · 2017-01-09Clinical Trial Update: Open-label, Pharmacokinetic, Safety and Efficacy Study of Adjunctive Brivaracetam in Children With Epilepsy. [Phase 2]
Phase 2 open-label pharmacokinetic and safety/efficacy study of adjunctive brivaracetam in children with epilepsy completed with results pos…